Your browser doesn't support javascript.
loading
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis.
Wang, Xiaoli; Tirucherai, Giridhar; Marbury, Thomas C; Wang, Jessie; Chang, Ming; Zhang, Donglu; Song, Yan; Pursley, Janice; Boyd, Rebecca A; Frost, Charles.
Afiliação
  • Wang X; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Tirucherai G; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Marbury TC; Orlando Clinical Research Center, Orlando, FL, USA.
  • Wang J; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Chang M; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Zhang D; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Song Y; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Pursley J; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Boyd RA; Pfizer Inc, Groton, CT, USA.
  • Frost C; At time of research, Bristol-Myers Squibb, Princeton, NJ, USA.
J Clin Pharmacol ; 56(5): 628-36, 2016 May.
Article em En | MEDLINE | ID: mdl-26331581
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Diálise Renal / Inibidores do Fator Xa / Falência Renal Crônica Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Diálise Renal / Inibidores do Fator Xa / Falência Renal Crônica Idioma: En Ano de publicação: 2016 Tipo de documento: Article